Sonnet BioTherapeutics Holdings's total assets for Q3 2024 were $5.80M, a decrease of -1.91% from the previous quarter. SONN total liabilities were $3.18M for the fiscal quarter, a 11.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.